These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20405181)

  • 21. Long term follow up of multifocal motor neuropathy with conduction block under treatment.
    Azulay JP; Rihet P; Pouget J; Cador F; Blin O; Boucraut J; Serratrice G
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):391-4. PubMed ID: 9120457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifocal motor neuropathy: diagnosis and treatment.
    Pestronk A
    Neurology; 1998 Dec; 51(6 Suppl 5):S22-4. PubMed ID: 9851726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoadsorption in multifocal motor neuropathy.
    Finsterer J; Derfler K
    J Immunother; 1999 Sep; 22(5):441-2. PubMed ID: 10546160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial.
    Piepers S; Van den Berg-Vos R; Van der Pol WL; Franssen H; Wokke J; Van den Berg L
    Brain; 2007 Aug; 130(Pt 8):2004-10. PubMed ID: 17626040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensory loss in multifocal motor neuropathy: a clinical and electrophysiological study.
    Lambrecq V; Krim E; Rouanet-Larrivière M; Lagueny A
    Muscle Nerve; 2009 Feb; 39(2):131-6. PubMed ID: 19127532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MULTIFOCAL MOTOR NEUROPATHY: CASE REPORTS.
    Jusufović E; Sinanović O; Zukić S; Burina A; Džinić Jusufović Z; Šakić A
    Acta Clin Croat; 2018 Sep; 57(3):581-587. PubMed ID: 31168193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy.
    Comi G; Amadio S; Galardi G; Fazio R; Nemni R
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):35-7. PubMed ID: 7964850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motor conduction block and high titres of anti-GM1 ganglioside antibodies: pathological evidence of a motor neuropathy in a patient with lower motor neuron syndrome.
    Adams D; Kuntzer T; Steck AJ; Lobrinus A; Janzer RC; Regli F
    J Neurol Neurosurg Psychiatry; 1993 Sep; 56(9):982-7. PubMed ID: 8410039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block.
    Nobile-Orazio E; Cappellari A; Meucci N; Carpo M; Terenghi F; Bersano A; Priori A; Barbieri S; Scarlato G
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):761-6. PubMed ID: 12023421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The node of Ranvier in multifocal motor neuropathy.
    Franssen H
    J Clin Immunol; 2014 Jul; 34 Suppl 1():S105-11. PubMed ID: 24801202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone.
    Pestronk A; Choksi R; Blume G; Lopate G
    Neurology; 1997 Apr; 48(4):1104-6. PubMed ID: 9109910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased frequency of HLA-DRB1*15 in patients with multifocal motor neuropathy.
    Sutedja NA; Otten HG; Cats EA; Piepers S; Veldink JH; van der Pol WL; van den Berg LH
    Neurology; 2010 Mar; 74(10):828-32. PubMed ID: 20211906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifocal motor neuropathy in Austria: a nationwide survey of clinical features and response to treatment.
    Löscher WN; Oberreiter EM; Erdler M; Quasthoff S; Culea V; Berek K; Embacher N; Grinzinger S; Hess I; Höger FS; Horlings CGC; Huemer M; Jecel J; Kleindienst W; Laich E; Müller P; Oel D; Örtl W; Lenzenweger E; Rath J; Stadler K; Stieglbauer K; Thaler-Wolf C; Wanschitz J; Zimprich F; Cetin H; Topakian R
    J Neurol; 2018 Dec; 265(12):2834-2840. PubMed ID: 30259176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study.
    Azulay JP; Blin O; Pouget J; Boucraut J; Billé-Turc F; Carles G; Serratrice G
    Neurology; 1994 Mar; 44(3 Pt 1):429-32. PubMed ID: 8145910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune pathogenesis and treatment of multifocal motor neuropathy.
    Vlam L; van den Berg LH; Cats EA; Piepers S; van der Pol WL
    J Clin Immunol; 2013 Jan; 33 Suppl 1():S38-42. PubMed ID: 22941513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of multifocal motor neuropathy with IgM lambda anti-GM1 antibody and IgM kappa paraprotein reacting exclusively with GM2].
    Arai M; Kusunoki S
    Rinsho Shinkeigaku; 2009; 49(2-3):123-6. PubMed ID: 19348179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic motor axonal neuropathy.
    Riva N; Gallia F; Iannaccone S; Corbo M; Terenghi F; Lazzerini A; Cerri F; Comi G; Quattrini A; Nobile-Orazio E
    J Peripher Nerv Syst; 2011 Dec; 16(4):341-6. PubMed ID: 22176149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of multifocal motor neuropathy with intravenous immunoglobulin.
    Koski CL
    J Clin Immunol; 2014 Jul; 34 Suppl 1():S127-31. PubMed ID: 24699885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN.
    Piepers S; Jansen MD; Cats EA; van Sorge NM; van den Berg LH; van der Pol WL
    J Neuroimmunol; 2010 Dec; 229(1-2):256-62. PubMed ID: 20920831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiologic findings in multifocal motor neuropathy.
    Katz JS; Wolfe GI; Bryan WW; Jackson CE; Amato AA; Barohn RJ
    Neurology; 1997 Mar; 48(3):700-7. PubMed ID: 9065551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.